The Role of Calprotectin in the Diagnosis and Treatment of Inflammatory Bowel Disease
International Journal of Molecular Sciences · 25.02.2025 · 26 (5) · 1996
DOI: 10.3390/ijms26051996 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.02.2025. Verfasst von Wenqian Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China. Hauptthemen laut MEDLINE: Leukocyte L1 Antigen Complex, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dalian Medical University Foundation for Teaching Reform Project of Undergraduate Innovative Talents Training, Liaoning Province Science and Technology Plan Alliance Fund project.
Abstract (Originalsprache)
The management of inflammatory bowel disease (IBD), which is characterized by immunodeficiency, has attracted increasing attention, highlighting the necessity for more precise and streamlined diagnostic approaches in clinics. Calprotectin, an immune cell-derived protein with inherent anti-inflammatory and antimicrobial properties, plays a pivotal role in immune regulation and intestinal homeostasis. Its expression levels are intricately linked to IBD activity, enabling differentiation between inflammatory and non-inflammatory states while predicting recurrence risks. As a non-invasive biomarker, fecal calprotectin (FC) and serum calprotectin (SC) analysis offers high reproducibility and clinical utility, facilitating both IBD diagnosis and real-time disease monitoring. Beyond its diagnostic specificity in distinguishing IBD from other gastrointestinal disorders, calprotectin also emerges as a promising therapeutic target, due to its dual role in modulating inflammatory pathways and interacting with the gut microbiota. With collaborative advancements in standardized detection protocols and innovative research methodologies, it is anticipated that calprotectin-based strategies will be integrated into mainstream clinical practice for IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China.
- Comparative Medicine Department of Researching and Teaching, Dalian Medical University, Dalian 116044, China.
Förderung
- Dalian Medical University Foundation for Teaching Reform Project of Undergraduate Innovative Talents Training
- Liaoning Province Science and Technology Plan Alliance Fund project
Zitieren
APA
Wang, W., Cao, W., Zhang, S., Chen, D., & Liu, L. (2025). The Role of Calprotectin in the Diagnosis and Treatment of Inflammatory Bowel Disease. International Journal of Molecular Sciences, 26(5), 1996. https://doi.org/10.3390/ijms26051996
Vancouver
Wang W, Cao W, Zhang S, Chen D, Liu L. The Role of Calprotectin in the Diagnosis and Treatment of Inflammatory Bowel Disease. International Journal of Molecular Sciences. 2025;26(5):1996. doi:10.3390/ijms26051996
BibTeX
@article{Wang2025,
author = {Wang, Wenqian and Cao, Wenfu and Zhang, Shenyun and Chen, Dapeng and Liu, Lihong},
title = {The Role of Calprotectin in the Diagnosis and Treatment of Inflammatory Bowel Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {5},
pages = {1996},
doi = {10.3390/ijms26051996}
}
EUVIMED